Filing Details
- Accession Number:
- 0001385508-22-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-16 16:03:23
- Reporting Period:
- 2022-05-13
- Accepted Time:
- 2022-05-16 16:03:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385508 | Opiant Pharmaceuticals Inc. | OPNT | Pharmaceutical Preparations (2834) | 464744124 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1685788 | L. Ann Macdougall | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd., Suite 400 Santa Monica CA 90401 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-13 | 3,000 | $10.93 | 26,179 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
